Fig. 7From: Folic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancerIn vivo MR imaging of intraperitoneal tumor after intravenous injection of FA-targeted Fe3O4 NPs or non-targeted Fe3O4 NPs (0.6Â mg Fe) at different time pointsBack to article page